Put Options

17 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2024

May 13, 2024

SELL
$3.76 - $6.02 $189,504 - $303,408
-50,400 Reduced 99.8%
100 $0
Q3 2023

Nov 13, 2023

SELL
$6.81 - $9.74 $1.46 Million - $2.09 Million
-215,000 Reduced 80.98%
50,500 $365,000
Q2 2023

Aug 07, 2023

SELL
$6.67 - $9.52 $3.04 Million - $4.34 Million
-456,000 Reduced 63.2%
265,500 $1.97 Million
Q1 2023

May 08, 2023

BUY
$5.76 - $12.48 $1.99 Million - $4.31 Million
345,200 Added 91.74%
721,500 $5 Million
Q4 2022

Feb 01, 2023

BUY
$8.86 - $25.04 $2.53 Million - $7.14 Million
285,300 Added 313.52%
376,300 $3.87 Million
Q3 2022

Nov 10, 2022

SELL
$18.2 - $76.12 $1,820 - $7,612
-100 Reduced 0.11%
91,000 $1.66 Million
Q2 2022

Aug 03, 2022

SELL
$36.28 - $75.29 $1.86 Million - $3.86 Million
-51,300 Reduced 36.03%
91,100 $4.69 Million
Q1 2022

May 04, 2022

BUY
$69.73 - $142.9 $5.5 Million - $11.3 Million
78,900 Added 124.25%
142,400 $10.5 Million
Q2 2021

Aug 13, 2021

SELL
$121.0 - $257.67 $96,800 - $206,136
-800 Reduced 1.24%
63,500 $13.5 Million
Q1 2021

May 13, 2021

SELL
$112.98 - $319.93 $6.6 Million - $18.7 Million
-58,400 Reduced 47.6%
64,300 $11.7 Million
Q4 2020

Feb 12, 2021

BUY
$78.74 - $139.5 $472,439 - $837,000
6,000 Added 5.14%
122,700 $13.7 Million
Q3 2020

Nov 13, 2020

BUY
$79.44 - $178.51 $6.19 Million - $13.9 Million
77,900 Added 200.77%
116,700 $12.6 Million
Q2 2020

Aug 13, 2020

BUY
$13.86 - $83.61 $332,640 - $2.01 Million
24,000 Added 162.16%
38,800 $3.23 Million
Q1 2020

May 13, 2020

SELL
$3.93 - $16.0 $476,709 - $1.94 Million
-121,300 Reduced 89.13%
14,800 $200,000
Q4 2019

Feb 14, 2020

SELL
$3.69 - $5.22 $3,690 - $5,220
-1,000 Reduced 0.73%
136,100 $541,000
Q3 2019

Nov 14, 2019

BUY
$4.02 - $7.84 $44,621 - $87,024
11,100 Added 8.81%
137,100 $688,000
Q2 2019

Aug 14, 2019

BUY
$4.93 - $12.2 $621,180 - $1.54 Million
126,000 New
126,000 $738,000

Others Institutions Holding NVAX

About NOVAVAX INC


  • Ticker NVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,215,104
  • Market Cap $731M
  • Description
  • Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...
More about NVAX
Track This Portfolio

Track Wolverine Asset Management LLC Portfolio

Follow Wolverine Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Asset Management LLC with notifications on news.